These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9434785

  • 1. Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA.
    Fujimoto K, Takahashi M.
    Biochem Biophys Res Commun; 1997 Dec 29; 241(3):775-81. PubMed ID: 9434785
    [Abstract] [Full Text] [Related]

  • 2. Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
    Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J.
    Cancer Res; 2001 Oct 15; 61(20):7594-602. PubMed ID: 11606399
    [Abstract] [Full Text] [Related]

  • 3. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells.
    Feng R, Shen S, Hui H, Jin M.
    Chin Med J (Engl); 1997 Nov 15; 110(11):847-50. PubMed ID: 9772416
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of telomerase with human telomerase reverse transcriptase antisense increases the sensitivity of tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells.
    Gao XD, Chen YR.
    Asian J Androl; 2007 Sep 15; 9(5):697-704. PubMed ID: 17712489
    [Abstract] [Full Text] [Related]

  • 5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun 15; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

  • 6. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S, Kyo S, Banerjee PP.
    Cancer Res; 2006 Feb 15; 66(4):2107-15. PubMed ID: 16489011
    [Abstract] [Full Text] [Related]

  • 7. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
    Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ.
    Eur J Surg Oncol; 2002 Apr 15; 28(3):225-34. PubMed ID: 11944954
    [Abstract] [Full Text] [Related]

  • 8. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
    Li BD, Budnick RM, Russo CA, Anderson GR, Stewart CC.
    J Surg Res; 1995 Oct 15; 59(4):485-92. PubMed ID: 7564322
    [Abstract] [Full Text] [Related]

  • 9. Antisense inhibition of c-myc expression reveals common and distinct mechanisms of growth inhibition by TGF beta and TNF alpha.
    Robinson-Benion C, Salhany KE, Hann SR, Holt JT.
    J Cell Biochem; 1991 Feb 15; 45(2):188-95. PubMed ID: 2055946
    [Abstract] [Full Text] [Related]

  • 10. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H, Ishiguro H, Ikeda N, Hori M, Kubota Y, Uemura H.
    Int J Urol; 2005 Jan 15; 12(1):73-80. PubMed ID: 15661057
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.
    Devi GR, Oldenkamp JR, London CA, Iversen PL.
    Prostate; 2002 Nov 01; 53(3):200-10. PubMed ID: 12386920
    [Abstract] [Full Text] [Related]

  • 12. [Telomerase gene antisense oligodeoxynucleotide down-regulates telomerase activity in HL-60 cells].
    He DM, Zhang H.
    Ai Zheng; 2002 Oct 01; 21(10):1070-4. PubMed ID: 12508645
    [Abstract] [Full Text] [Related]

  • 13. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
    Chen YZ, Wu Y, Liang M, Li NN, Zhang ZX, Lu LH.
    Zhonghua Xue Ye Xue Za Zhi; 2003 Dec 01; 24(12):640-3. PubMed ID: 14761612
    [Abstract] [Full Text] [Related]

  • 14. Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.
    Duncan VE, Ajmani PS, Hughes JA.
    Anticancer Res; 1998 Dec 01; 18(6A):4105-8. PubMed ID: 9891453
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD, Chen YR.
    Chin Med J (Engl); 2007 May 05; 120(9):755-60. PubMed ID: 17531113
    [Abstract] [Full Text] [Related]

  • 16. Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.
    Zhang RG, Wang XW, Yuan JH, Xie H.
    Acta Pharmacol Sin; 2000 Aug 05; 21(8):742-6. PubMed ID: 11501185
    [Abstract] [Full Text] [Related]

  • 17. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
    Schneider-Stock R, Boltze C, Jäger V, Epplen J, Landt O, Peters B, Rys J, Roessner A.
    J Pathol; 2003 Apr 05; 199(4):517-25. PubMed ID: 12635143
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Antisense human telomerase reverse transcriptase inhibits leukemia cell proliferation in vitro].
    Sun LB, Li CR, Wen JM, Wang GB, Zhang M, Yang J, Li RX.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May 05; 24(5):521-4. PubMed ID: 15151822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.